Effects of a 12-week lifestyle intervention on health outcome and serum adipokines in middle-aged korean men with borderline high blood pressure

Journal of the American College of Nutrition

Volumn 31, Issue 5, 2012, Pages 352-360

  Kim, Eun Jin ^a   Cho, Sang Woon ^a   Kang, Ji Yeon ^a,b   Choi, Tae In ^b   Park, Yoo Kyoung ^a  

^a Kyung Hee University   (South Korea)

^b Korea Hydro & Nuclear Power Co   (South Korea)

Author keywords

Adipokine; Blood pressure; Lifestyle intervention; Obesity

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; C REACTIVE PROTEIN; CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LEPTIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SODIUM;

ADULT; ARTICLE; AWARENESS; BLOOD PRESSURE REGULATION; BODY FAT; BORDERLINE HYPERTENSION; CALORIC INTAKE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; EXERCISE; FOOD FREQUENCY QUESTIONNAIRE; GLUCOSE BLOOD LEVEL; HIP CIRCUMFERENCE; HUMAN; KOREA; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MALE; NUTRITION EDUCATION; NUTRITIONAL COUNSELING; NUTRITIONAL REQUIREMENT; OBESITY; PROTEIN BLOOD LEVEL; SODIUM INTAKE; SODIUM RESTRICTION; WAIST CIRCUMFERENCE; WEIGHT REDUCTION;

ADIPOKINES; ADIPOSE TISSUE; ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD GLUCOSE; BLOOD PRESSURE; BODY MASS INDEX; C-REACTIVE PROTEIN; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DIET, SODIUM-RESTRICTED; EXERCISE; FASTING; HUMANS; HYPERTENSION; INTERVENTION STUDIES; LEPTIN; LIFE STYLE; MALE; MIDDLE AGED; OBESITY; QUESTIONNAIRES; WEIGHT LOSS;

EID: 84876343770     PISSN: 07315724     EISSN: 15411087     Source Type: Journal    
DOI: 10.1080/07315724.2012.10720440     Document Type: Article

References (49)

1. MacMahonS, PetoR, CutlerJ, CollinsR, SorlieP, NeatonJ, AbbottR, GodwinJ, DyerA, StamlerJ: Blood pressure, stroke, and coronary heart disease. Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet335:765-774, 1990.
2. KannelWB, WilsonPW, ZhangTJ: The epidemiology of impaired glucose tolerance and hypertension. Am Heart J121:1268-1273, 1991.
3. Korean National Statistical Office: “Report on the Causes of Death in Korea.” Seoul: Korean National Statistical Office, 2009.
4. KosugiT, NakagawaT, KamathD, JohnsonRJ: Uric acid and hypertension: An age-related relationship?J Hum Hypertens23:75-76, 2009.
5. DicksonME, SigmundCD: Genetic basis of hypertension: revisiting angiotensinogen. Hypertension48:14-20, 2006.
6. LumaGB, SpiottaRT: Hypertension in children and adolescents. Am Fam Physician73:1558-1568, 2006.
7. JonesDW, KimJS, AndrewME, KimSJ, HongYP: Body mass index and blood pressure in Korean men and women: the Korean National Blood Pressure Survey. J Hypertens12:1433-1437, 1994.
8. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ; Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee: Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension42:1206-1252, 2003.
9. AshleyFW Jr, KannelWB: Relation of weight change to changes in atherogenic traits: the Framingham study. J Chronic Dis 27:103-114, 1974.
10. HubertHB, FeinleibM, McNamaraPM, CastelliWP: Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham heart study. Circulation67:968-977, 1983.
11. HigginsM, KannelW, GarrisonR, PinskyJ, StokesJ 3rd: Hazards of obesity—the Framingham experience. Acta Med Scand Suppl723:23-36, 1988.
12. RocchiniAP, KeyJ, BondieD, ChicoR, MooreheadC, KatchV, MartinM: The effect of weight loss on the sensitivity of blood pressure to sodium in obese adolescents. N Engl J Med 321:580-585, 1989.
13. HeJ, WheltonPK, AppelLJ, CharlestonJ, KlagMJ: Long-term effects of weight loss and dietary sodium reduction on incidence of hypertension. Hypertension35:544-549, 2000.
14. BouloumieA, MarumoT, LafontanM, BusseR: Leptin induces oxidative stress in human endothelial cells. FASEB J 13:1231-1238, 1999.
15. QuehenbergerP, ExnerM, Sunder-PlassmannR, RuzickaK, BieglmayerC, EndlerG, MuellnerC, SpeiserW, WagnerO: Leptin induces endothelin-1 in endothelial cells in vitro. Circ Res90:711-718, 2002.
16. FasshauerM, KleinJ, NeumannS, EszlingerM, PaschkeR: Adiponectin gene expression is inhibited by beta-adrenergic stimulation via protein kinase A in 3T3-L1 adipocytes. FEBS Lett507:142-146, 2001.
17. FainJN, MadanAK, HilerML, CheemaP, BahouthSW: Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. Endocrinology145:2273-2282, 2004.
18. BravoPE, MorseS, BorneDM, AguilarEA, ReisinE: Leptin and hypertension in obesity. Vasc Health Risk Manag2:163-169, 2006.
19. TuneJD, ConsidineRV: Effects of leptin on cardiovascular physiology. J Am Soc Hypertens1:231-241, 2007.
20. MallamaciF, ZoccaliC, CuzzolaF, TripepiG, CutrupiS, ParlongoS, TanakaS, OuchiN, KiharaS, FunahashiT, MatsuzawaY: Adiponectin in essential hypertension. J Nephrol15:507-511, 2002.
21. AdamczakM, WiecekA, FunahashiT, ChudekJ, KokotF, MatsuzawaY: Decreased plasma adiponectin concentration in patients with essential hypertension. Am J Hypertens16:72-75, 2003.
22. KazumiT, KawaguchiA, SakaiK, HiranoT, YoshinoG: Young men with high-normal blood pressure have lower serum adiponectin, smaller LDL size, and higher elevated heart rate than those with optimal blood pressure. Diabetes Care25:971-976, 2002.
23. IwashimaY, KatsuyaT, IshikawaK, OuchiN, OhishiM, SugimotoK, FuY, MotoneM, YamamotoK, MatsuoA, OhashiK, KiharaS, FunahashiT, RakugiH, MatsuzawaY, OgiharaT: Hypoadiponectinemia is an independent risk factor for hypertension. Hypertension43:1318-1323, 2004.
24. ChowWS, CheungBM, TsoAW, XuA, WatNM, FongCH, OngLH, TamS, TanKC, JanusED, LamTH, LamKS: Hypoadiponectinemia as a predictor for the development of hypertension: a 5- year prospective study. Hypertension49:1455-1461, 2007.
25. AtaSM, VaishnavU, PuglisiM, LofgrenIE, WoodRJ, VolekJS, FernandezML: Macronutrient composition and increased physical activity modulate plasma adipokines and appetite hormones during a weight loss intervention. J Women Health (Larchmt) 19:139-145, 2010.
26. LeeIS, ShinG, ChoueR: A 12-week regimen of caloric restriction improves levels of adipokines and pro-inflammatory cytokines in Korean women with BMIs greater than 23 kg/m2. Inflamm Res59:399-405, 2010.
27. WolfeBE, JimersonDC, OrlovaC, MantzorosCS: Effect of dieting on plasma leptin, soluble leptin receptor, adiponectin and resistin levels in healthy volunteers. Clin Endocrinol (Oxf)61:332-338, 2004.
28. KobayashiJ, MuraseY, AsanoA, NoharaA, KawashiriMA, InazuA, YamagishiM, MabuchiH: Effect of walking with a pedometer on serum lipid and adiponectin levels in Japanese middle-aged men. J Atheroscler Thromb13:197-201, 2006.
29. CambuliVM, MusiuMC, IncaniM, PaderiM, SerpeR, MarrasV, CossuE, CavalloMG, MariottiS, LocheS, BaroniMG: Assessment of adiponectin and leptin as biomarkers of positive metabolic outcomes after lifestyle intervention in overweight and obese children. J Clin Endocrinol Metab93:3051-3057, 2008.
30. SonSM, ParkYS, LimWJ, KimSB, JeongY-S: Development and evaluation of validity of short Dish Frequency Questionnaire (DFQ) for estimation of habitual sodium intake for Korean adults. Korean J Community Nutr12:838-853, 2007.
31. Stevens VJ, Obarzanek E, Cook NR, Lee IM, Appel LJ, Smith West D, Milas NC, Mattfeldt-Beman M, Belden L, Bragg C, Millstone M, Raczynski J, Brewer A, Singh B, Cohen J; Trials for the Hypertension Prevention Research Group: Long-term weight loss and changes in blood pressure: results of the Trials of Hypertension Prevention, phase II. Ann Intern Med134:1-11, 2001.
32. StaessenJ, FagardR, AmeryA: The relationship between body weight and blood pressure. J Hum Hypertens2:207-217, 1988.
33. NeterJE, StamBE, KokFJ, GrobbeeDE, GeleijnseJM: Influence of weight reduction on blood pressure: a meta-analysis of randomized controlled trials. Hypertension42:878-884, 2003.
34. NoakesM, KeoghJB, FosterPR, CliftonPM: Effect of an energyrestricted, high-protein, low-fat diet relative to a conventional highcarbohydrate, low-fat diet on weight loss, body composition, nutritional status, and markers of cardiovascular health in obese women. Am J Clin Nutr81:1298-1306, 2005.
35. FarnsworthE, LuscombeND, NoakesM, WittertG, ArgyiouE, CliftonPM: Effect of a high-protein, energy-restricted diet on body composition, glycemic control, and lipid concentrations in overweight and obese hyperinsulinemic men and women. Am J Clin Nutr78:31-39, 2003.
36. BimenyaGS, OkotJK, NangosaH, AngumaSA, ByarugabaW: Plasma cholesterol and related lipid levels of seemingly healthy public service employees in Kampala, Uganda. Afr Health Sci6:139-144, 2006.
37. American Diabetes Association: Executive summary: Standards of medical care in diabetes—2010. Diabetes Care33:S4-S10, 2010.
38. WoleverTM, HamadS, ChiassonJL, JosseRG, LeiterLA, RodgerNW, RossSA, RyanEA: Day-to-day consistency in amount and source of carbohydrate intake associated with improved blood glucose control in type 1 diabetes. J Am Coll Nutr18:242-247, 1999.
39. FordES: Body mass index, diabetes, and C-reactive protein among U.S. adults. Diabetes Care22:1971-1977, 1999.
40. Sacks FM, Svetkey LP, Vollmer WM, Appel LJ, Bray GA, Harsha D, Obarzanek E, Conlin PR, Miller ER 3rd, Simons-Morton DG, Karanja N, Lin PH; DASH-Sodium Collaborative Research Group: Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH- Sodium Collaborative Research Group. N Engl J Med344:3-10, 2001.
41. McCarronDA, MetzJA, HattonDC: Mineral intake and blood pressure in African Americans. Am J Clin Nutr68:517-518, 1998.
42. McCarronDA, ReusserME: Are low intakes of calcium and potassium important causes of cardiovascular disease?Am J Hypertens14:S206-S212, 2001.
43. WheltonPK, HeJ, CutlerJA, BrancatiFL, AppelLJ, FollmannD, KlagMJ: Effects of oral potassium on blood pressure. Metaanalysis of randomized controlled clinical trials. JAMA 277:1624-1632, 1997.
44. GriffithLE, GuyattGH, CookRJ, BucherHC, CookDJ: The influence of dietary and nondietary calcium Supplementation on blood pressure: an updated metaanalysis of randomized controlled trials. Am J Hypertens12:84-92, 1999.
45. SilhaJV, KrsekM, SkrhaJV, SuchardaP, NyombaBL, MurphyLJ: Plasma resistin, adiponectin and leptin levels in lean and obese subjects: correlations with insulin resistance. Eur J Endocrinol149:331-335, 2003.
46. MurakamiK, SasakiS, TakahashiY, UenishiK, YamasakiM, HayabuchiH, GodaT, OkaJ, BabaK, OhkiK, WatanabeR, SugiyamaY: Nutrient and food intake in relation to serum leptin concentration among young Japanese women. Nutrition 23:461-468, 2007.
47. ThongFS, HudsonR, RossR, JanssenI, GrahamTE: Plasma leptin in moderately obese men: independent effects of weight loss and aerobic exercise. Am J Physiol Endocrinol Metab 279:E307-E313, 2000.
48. CarlyleM, JonesOB, KuoJJ, HallJE: Chronic cardiovascular and renal actions of leptin: role of adrenergic activity. Hypertension39:496-501, 2002.
49. CorreiaML, MorganDA, SivitzWI, MarkAL, HaynesWG: Leptin acts in the central nervous system to produce dosedependent changes in arterial pressure. Hypertension37:936-942, 2001.